Associations Between Time to Reduction and Complications in Patients With Dislocated Total Hip Arthroplasty

NCT ID: NCT07132723

Last Updated: 2025-08-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

3700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-20

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to investigate the impact of time to closed reduction on both patient related and organizational factors. These include, length of stay, hospitalization, admission to intensive care unit, rehospitalizations, delirium, all-cause mortality, infection requiring hospital contact, and cardiovascular complications. It is also intended to investigate whether different anaesthetic strategies and airway management are associated with different complication rates.

It is hypothesized that longer waiting time until reduction increase the postoperative length of stay, readmissions, and risk of complications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Closed Reduction Arthroplasty, Replacement, Hip Length of Stay

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients underwent closed reduction of dislocated THA

adults presenting with a dislocated THA, who underwent closed reduction in an operating theatre with anesthesiology being involved, in public hospitals

Time in minutes from admission to closed reduction

Intervention Type OTHER

Time in minutes from admission to closed reduction measured as: From arriving time in the emergency department until the start of surgery in the operating theater.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Time in minutes from admission to closed reduction

Time in minutes from admission to closed reduction measured as: From arriving time in the emergency department until the start of surgery in the operating theater.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

- Time of day - Weekday vs. weekend - Airway management - Anesthesia method(s) - Neuromuscular blocking agent (Yes/No)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients will be considered eligible for inclusion if they meet all of the following criteria:

* Aged 18 years or older
* Presented to the emergency department with a dislocated total hip arthroplasty.
* Undergo closed reduction of the dislocated total hip arthroplasty in the operating theatre, with the involvement of the Department of Anesthesiology.

Exclusion Criteria

* Were primarily booked for open surgical reduction.
* Did not have a complete case log (i.e. time of admission; referral to the operation theatre; anesthesia induction; discharge, etc.) and we were unable to recreate the log using simple code rules.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nordsjaellands Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Anesthesiology, North Zeeland Hospital

Hillerød, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lars H Lundstrøm, MD, PhD

Role: CONTACT

+4548296512

Rikke HF Bjulf, Research fellow

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lars Lundstrøm

Role: primary

+4548296512

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HIP_REDUCTION

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Q-REDUCE Study
NCT06639334 NOT_YET_RECRUITING NA
Time to Hip Fracture Surgery
NCT03749122 COMPLETED